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The intestinal immune system has to strike a delicate balance between initiating inflammatory responses
against invading bacterial pathogens and avoiding their induction against microbiota colonizing the lumen.
Adequate inflammatory responses against bacterial invasion result in the lumenal secretion of antimicrobial
peptides, as well as the release of cytokines in tissue that recruit and activate phagocytes. However, path-
ogens have evolved to utilize these environmental changes in the inflamed intestine to promote colonization.
This review focuses on the costs and benefits of intestinal inflammation and the fine interplay between the
host, its microbiota, and enteric pathogens.Introduction
The healthy intestine is permanently populated with a diverse
microbial community, termed the microbiota, which is com-
posed of over 300 different species of prokaryotic and eukary-
otic microorganisms. The microbiota provide benefit to the
host by supplying nutrients and offering some protection against
colonization by pathogens. This complex bacterial community
reaches densities of 1010–1011 organisms per gram of lumenal
content in the large intestine. One challenge to the intestinal
immune system is to avoid an excessive immune response
against this large lumenal microbial community, while at the
same time maintaining the ability to trigger an appropriate
inflammatory response against the introduction of microbes
into tissue, which may occur after an injury to the epithelium or
a crossing of the epithelial barrier by invasive pathogens. This
task is accomplished by several sentinel functions that enable
the host to detect a compromised barrier and immediately
initiate an appropriate inflammatory response. The rapid induc-
tion of innate defenses is designed to limit microbial dissemina-
tion and either clear the infection or control it until the host can
mount specific adaptive immune responses. However, acute
intestinal inflammation can also harm the host, because it is
associated with diarrhea and changes in the intestinal environ-
ment that can be exploited by pathogens. Here, we review recent
advances in microbial pathogenesis and innate immunity that
provide new insights into the costs and benefits of acute intes-
tinal inflammation.
Sentinel Functions for Surveillance of Microbial
Translocation from the Gut
The innate immune system senses microbial translocation into
tissue by detecting conserved microbe-specific molecular
patterns using three major pattern recognition systems: Toll-
like receptors (TLRs), nucleotide-binding and oligomerization
domain (Nod)-like receptors (NLRs), and complement (Figure 1).
TLRs are located on the host cell surface or in a vesicular
compartment and function as a ‘‘bar code reader’’ that distin-
guishes bacterial patterns from those associated with viral
agents. For example, the presence of viral nucleic acids is
detected through TLR3, TLR7, and TLR8, while TLR1, TLR2,
TLR4, TLR5, and TLR6 recognize products that are unique to36 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.bacteria (reviewed in Iwasaki and Medzhitov [2004]). To distin-
guish between lumenal bacteria and those present in intestinal
tissue, expression of TLRs is compartmentalized in intestinal
epithelial cells. For example, TLR5, which recognizes bacterial
flagellin, is expressed at the basolateral surface of human intes-
tinal epithelial cells (Gewirtz et al., 2001), while TLR4, which
recognizes the lipid A moiety of lipopolysaccharide (LPS) from
Gram-negative bacteria, is found in vesicular structures in the
cytoplasm of these cells (Hornef et al., 2002). This functional
compartmentalization of TLRs enables the epithelium to serve
as a sentinel for microbial translocation from the intestinal lumen.
A second line of sentinel cells is formed by myofibroblasts,
myeloid-derived antigen-presenting cells localized in the base-
ment membrane directly beneath the intestinal epithelium where
they monitor bacterial intrusion by expressing TLR4 (Walton
et al., 2009). As bacteria penetrate deeper into tissue, they
encounter phagocytes, such as macrophages and dendritic
cells. The majority of resident intestinal macrophages in humans
lack expression of TLR4 and its coreceptor, CD14, under normal
conditions. These macrophages are refractory to inflammatory
cytokine production, but they display potent phagocytic activity
to removemicrobes (reviewed inWeber et al. [2009]). In contrast,
resident intestinal dendritic cells respond to stimulation with
TLR ligands and are important sources of cytokine production
during infection.
The second family of pattern recognition systems, termed
NLRs, is located in the host cell cytosol. Some NLRs function
in detecting the presence of viral nucleic acids in the cytoplasm.
However, the majority of enteric bacterial agents are extracel-
lular or remain within a vesicular compartment and thus do not
come into direct contact with NLRs (although there are few
notable exceptions, such as Listeria monocytogenes and
Shigella spp., which can reside in the cytosol). Nonetheless,
NLRs function as an important sensory system for bacterial
‘‘patterns of pathogenesis,’’ detecting for instance the presence
of virulence factors, such as toxins, type III secretion systems
(T3SS), or type IV secretion systems (T4SS) produced by patho-
gens that do not enter the cytoplasm (reviewed in Vance et al.
[2009]). For example, the invasive enteric pathogen Salmonella
enterica serotype Typhimurium (S. Typhimurium) deploys a
T3SS to inject proteins into the host cell cytosol, which induces
Figure 1. Host Factors Involved in Orchestrating Exudative Intestinal Inflammation during the Early (Innate) Phase of a Bacterial Infection
Detection of bacteria by innate immune sensors (complement, TLRs, and NLRs) results in an initiating response (C3a, C5a, IL-23, IL-1b, and IL-18) that helps
to amplify inflammatory signals in tissue by nonspecifically stimulating immune cells (macrophages, mast cells, T cells) to release inflammatory mediators
(histamine, CXC chemokines, TNF-a, IL-17, IL-22, and IFN-g), which promote neutrophil recruitment, acutely increased vascular permeability, and the formation
of tissue exudates.
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invasion of the intestinal epithelium (reviewed in Zhou and Gala´n
[2001]). The operation of this T3SS is accompanied, perhaps
inadvertently, by translocation of flagellin, the structural compo-
nent of flagella, into the cytosol of macrophages (Sun et al.,
2007), which is detected as a ‘‘pattern of pathogenesis’’ by
a NLR termed NLRC4, formerly known as Ipaf, an acronym for
interleukin (IL)-1b-converting enzyme (ICE) protease-activating
factor (Franchi et al., 2006; Miao et al., 2006). In turn, Ipaf acti-
vates caspase-1, resulting in pyroptotic cell death, which is
accompanied by proteolytic activation of IL-1b and IL-18 (Bergs-
baken et al., 2009). Caspase-1 can also become activated during
S. Typhimurium infection by a T3SS-dependent injection of
SopE, a protein involved in host cell invasion, into the host cell
cytosol (Mu¨ller et al., 2009). Helicobacter pylori, a noninvasive
pathogen residing in the gastric lumen in close association
with the epithelium, uses a T4SS to inject the CagA protein into
host cells to manipulate their physiology. A byproduct of oper-
ating the T4SS is the delivery of cell wall fragments (muropepti-des) into the host cell cytoplasm, a process sensed by the Nod1
protein (Viala et al., 2004). Nod1 and Nod2, a second intracellular
sensor of bacterial cell wall fragments (Girardin et al., 2003), are
expressed in the intestinal epithelium and may enable these
sentinels to detect lumenal pathogens that manipulate host cell
physiology using secretion systems.
The third pattern recognition system, complement, is a
humoral component of the host innate immune surveillance.
After crossing the epithelial lining, bacteria become exposed to
complement component 3 (C3), which can distinguish bacterial
surfaces from those of host cells or viruses. This pattern recog-
nition event represents the first step in the alternative pathway
of complement activation. Although rarely discussed in this
context, bacterial pattern recognition through C3 may act in
concert with bacterium-specific TLRs to distinguish the ‘‘bar
code’’ of bacteria from that of other groups of microbes. C3b,
one of the cleavage products of C3 generated during comple-
ment activation, contains a reactive thioester group, which forms
esters with hydroxyl groups of bacterial surface carbohydrates,Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 37
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positive bacteria. In the absence of specific antibodies, opsoni-
zation of bacteria by C3b is required for efficient phagocytosis by
neutrophils, macrophages, and dendritic cells, which proceeds
through complement receptor 3 (CR3, also known as CD11b/
CD18 or Mac1) and CR4 (also known as CD11c/CD18). Activa-
tion of the alternative pathway leads to the deposition of
complement components C5b, C6, C7, C8, andC9 on the bacte-
rial surface where these proteins assemble into a bactericidal
terminal membrane attack complex. Importantly, complement
activation generates the soluble fragments C3a and C5a, known
as the anaphylatoxins, which are potent inducers of inflamma-
tory responses (reviewed in Haas and van Strijp [2007]).
The Orchestration of Exudative Inflammation
It is clear from the above examples that pattern recognition
enables the host to detect a breach in the mucosal barrier, to
distinguish bacteria from other microbes (using TLRs and
complement), and in some cases, even to assess the pathogenic
potential of a bacterium (using NLRs). This information is inte-
grated to mount an inflammatory reaction that is appropriate to
the threat. For example, the host reacts to an acute viral infection
with inflammatory infiltrates that are dominated by macro-
phages, dendritic cells, and/or lymphocytes. In contrast, the
appropriate response to a bacterial infection is characterized
by acutely increased vascular permeability, infiltrates that are
dominated by neutrophils, and the formation of tissue exudates
(reviewed in Tsolis et al. [2008]). The latter pathological changes
in tissue are commonly referred to as exudative inflammation.
The development of exudative inflammation is in part orches-
trated by cytokines. The detection of bacteria by TLRs and NLRs
results in an initiating cytokine response that is limited in scope,
but includes the release of mediators, which in turn help to
amplify responses in tissue (Figure 1). One mediator initiating
the amplification of cytokine responses in tissue is IL-23, which
can be released by dendritic cells (van Beelen et al., 2007) or
CD14+ intestinal macrophages (Kamada et al., 2008). Production
of IL-23 in these cells is dependent on NF-kB and can result
from stimulation of bacterium-specific TLRs (Siegemund et al.,
2007) or the intracellular bacterial sensor Nod2 (van Beelen
et al., 2007). IL-23 amplifies cytokine responses by stimulating
antigen-experienced T helper (Th)17 cells, gd T cells, and natural
killer (NK) T cells to produce IL-17 and IL-22 (Godinez et al.,
2009; Goto et al., 2009; Rachitskaya et al., 2008). This cytokine
release during the initial stages of inflammation proceeds
through an antigen-independent mechanism (Guo et al., 2009),
resulting in a marked increase in IL-17 and IL-22 expression in
the ileal mucosa of naive animals within 2–5 hr after infection
with S. Typhimurium (Raffatellu et al., 2007, 2008). A second
mechanism amplifying cytokine responses in tissue is initiated
by a subset of NLRs that activate caspase-1. While transcription
of the genes encoding IL-1b and IL-18 is NF-kB dependent and
can be induced by stimulating bacterium-specific TLRs, these
cytokines are produced as inactive proforms that need to be
cleaved by caspase-1 to become biologically active. IL-18 can
amplify responses by stimulating antigen-experienced CD8+
T cells and Th1 cells to rapidly secrete interferon (IFN)-g early
during bacterial infection by an antigen-independent mechanism
(Guo et al., 2009; Srinivasan et al., 2007). Similarly, IL-1b induces38 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.the release of IL-17 from Th17 cells by a T cell receptor-indepen-
dent mechanism, thereby amplifying early effector responses
(Guo et al., 2009; Lee et al., 2010). The resulting increase in cyto-
kine production becomes apparent during infection with invasive
enteric pathogens, such as S. Typhimurium, where the products
of the above amplification mechanisms, IL-17, IL-22, and IFN-g,
are among the most prominently induced cytokines in intestinal
tissue during the early phases of inflammation (Godinez et al.,
2008; Raffatellu et al., 2008).
Activation of the alternative complement pathway by bacterial
surface carbohydrates stimulates exudative inflammation
through the generation of anaphylatoxins, the most potent of
which is C5a (reviewed in Guo and Ward [2005]). C5a stimulates
basophils and mast cells to release tumor necrosis factor
(TNF)-a and histamine (Figure 1). Histamine contributes to
inflammation by promoting vasodilation. Furthermore, C5a,
C3a, and histamine are mediators of endothelial contraction,
thereby contributing to the increased vascular permeability and
the formation of tissue exudates characteristic of exudative
inflammation. C5a is a potent neutrophil chemoattractant and
can therefore contribute directly to recruiting these cells. C5a
can also synergize with LPS in stimulating human leukocytes
to release IL-8, a member of the CXC chemokine family, a group
of neutrophil chemoattractants. Additional mechanisms contrib-
uting to neutrophil recruitment are mediated by IL-17, IL-1b, and
TNF-a, cytokines that stimulate epithelial cells to release CXC
chemokines (Cromwell et al., 1992; Raffatellu et al., 2008).
Thus, complement (through C5a), NLRs (through caspase-1-
mediated IL-1b production), and TLRs (through IL-17) cooperate
in generating exudative inflammatory infiltrates dominated by
neutrophils.
Inducible Mucosal Barrier Functions
and the Consequences of Their Failure
The benefit of exudative inflammation resides in the orchestra-
tion of three major antibacterial response arms that contribute
to barrier functions against microbial dissemination (Figure 2).
Each arm is designed to control bacteria residing in a different
host niche. One arm of the response is orchestrated by IFN-g
and is directed against intracellular bacteria. IFN-g-mediated
activation checks bacterial replication in macrophages, a
preferred target of intracellular pathogens. Neutrophil recruit-
ment represents a second arm and is directed against extracel-
lular bacteria in tissue. Once opsonized by C3b, extracellular
bacteria become efficiently phagocytosed and killed by neutro-
phils. A third arm has been discovered more recently and is
directed against lumenal bacteria. This part of the response is
orchestrated by IL-22, which stimulates a lumenal release of
antimicrobials by epithelial cells (Raffatellu et al., 2009; Zheng
et al., 2008). The antimicrobial mechanisms induced in the intes-
tinal epithelium during inflammation include the release of
proteins mediating iron and zinc deprivation (lipocalin-2 and cal-
protectin, respectively), a bactericidal C-type lectin (regenerat-
ing islet-derived 3 gamma [RegIIIg]), antimicrobial peptides
(defensins), nitric oxide produced by inducible nitric oxide syn-
thase (iNOS), oxygen radicals produced by dual oxidase 2
(Duox2), and increased mucus production (Mejı´as-Luque et al.,
2010; Raffatellu et al., 2009; Zheng et al., 2008). These antimicro-
bial mechanisms are likely aimed at clearing lumenal bacteria
Figure 2. The Three Arms of an Innate
Antibacterial Response Mounted during
Exudative Intestinal Inflammation
IFN-g-activated macrophages combat intracel-
lular bacteria while neutrophils phagocytose
and kill extracellular bacteria in tissue. Lumenal
bacteria are targeted by epithelial-derived antimi-
crobials.
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Zheng et al., 2008).
The advantages conferred by the antibacterial barrier func-
tions orchestrated during exudative inflammation are illustrated
by clinical manifestations associated with their inactivation.
For example, patients with mutations in genes that encode
components of the IFN-g axis exhibit increased susceptibility
to disseminated infections with nontyphoidal Salmonella sero-
types, suggesting that an inhibition of bacterial replication in
macrophages contributes to mucosal barrier functions (Lammas
et al., 2002; MacLennan et al., 2004).
Neutrophils form a second important barrier against systemic
bacterial dissemination. This defense is not only effective against
classical extracellular bacteria, but also against the extracellular
stages of some facultative intracellular pathogens that may be
present during their transition between host cells. For example,
the facultative intracellular pathogen S. Typhimurium causes
a localized gastroenteritis in immunocompetent individuals,
while neutropenic patients develop a life threatening bacteremia
(Noriega et al., 1994; Tumbarello et al., 1995). A second condi-
tion predisposing to the development of S. Typhimurium bacter-
emia is an advanced HIV infection (reviewed in Gordon [2008]).
IL-17 deficiency has recently been identified as the immune
defect responsible for this clinical observation (Raffatellu et al.,
2008). In addition to impairing neutrophil recruitment, Th17
depletion also reduces IL-17 production in the bone marrow,
which in turn prevents production of granulocyte-colony stimu-
lating factor (G-CSF), a cytokine required for granulopoiesis
(Ye et al., 2001). This results in reduced microbicidal activity of
neutrophils from patients with advanced HIV disease (Coffey
et al., 1998; George et al., 1998). S. Typhimurium bacteremia is
also associated with other conditions resulting in a reduced
microbicidal activity of neutrophils (Humbert et al., 1990; TauberCell Host & Microet al., 1983), including chronic granulo-
matous disease (Winkelstein et al., 2000)
and sickle cell anemia (Okuonghae
et al., 1993).
The importance of neutrophils in
checking bacterial dissemination is
further highlighted by the fact that major
virulence factors of enteric pathogens
associated with systemic infections in
immunocompetent individuals are de-
signed to outmaneuver this barrier func-
tion. For instance, unlike commensal
Escherichia coli or E. coli isolates associ-
ated with localized enteric infections,
E. coli isolates associated with newborn
meningitis (NMEC) express a capsularpolysaccharide (CPS), termed the K1 antigen. Expression of
the K1 antigen lowers C3b fixation on the bacterial surface,
thereby reducing opsonophagocytosis by neutrophils (Horwitz
and Silverstein, 1980). S. enterica serotype Typhi (S. Typhi),
which causes a severe systemic infection termed typhoid fever,
expresses a CPS termed the Vi antigen. The Vi antigen is absent
from closely related pathogens, such as S. Typhimurium, which
cause a localized enteric infection in immunocompetent individ-
uals. Expression of the Vi antigen correlates with reduced C3b
fixation and reduced opsonophagocytosis of clinical S. Typhi
isolates (Looney and Steigbigel, 1986). Similarly, the food-borne
pathogen Brucella abortus disseminates to internal organs and
synthesizes a linear O-antigen, which prevents C3b fixation
(Barquero-Calvo et al., 2007). In conclusion, evasion of opsono-
phagocytosis by neutrophils is a shared virulence strategy of
pathogens, including NMEC, S. Typhi, and B. abortus, which
are able to cross the mucosal barrier of the gastrointestinal tract
and disseminate to internal organs. In contrast, C3b is efficiently
deposited on the surfaces of closely related organisms, such
as commensal E. coli, E. coli isolates associated with enteric
infections, or S. Typhimurium, thereby rendering them unable
to overcome a neutrophil barrier and disseminate to internal
organs in immunocompetent individuals.
Finally, antimicrobial mechanisms induced in the intestinal
epithelium during inflammation constitute a third barrier function,
which is directed against translocation of lumenal bacteria. For
example, infection with HIV is associated with increased translo-
cation of gut microbiota (Brenchley et al., 2006). Studies in
rhesus macaques infected with simian immunodeficiency virus
(SIV) show that increased microbial translocation from the gut
is associated with reduced IL-17 and IL-22 production in the
intestinal mucosa resulting from a depletion of Th17 cells (Raffa-
tellu et al., 2008). Depletion of CD4+ T cells, which includes thebe 8, July 22, 2010 ª2010 Elsevier Inc. 39
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a mouse model (Gautreaux et al., 1994), which supports the
idea that cytokines produced by these cells are important for
maintaining mucosal barrier functions. Translocation of gut
microbiota is furthermore a contributing factor in the pathogen-
esis of inflammatory bowel disease (IBD), a condition in which
the host develops an excessive inflammatory reaction against
intestinal microbial communities by unknown mechanisms. For
instance, preventing the induction of barrier functions by inacti-
vation of TLR4 increases microbial translocation, thereby exac-
erbating intestinal inflammation in models of IBD (Fukata et al.,
2005). Conversely, cytokines that enhance barrier functions
against microbiota translocation, including IL-23 and IL-22,
confer protection against IBD (Duerr et al., 2006; Zenewicz
et al., 2008). Collectively, these data support the concept that
orchestration by the IL-23/IL-22 axis of epithelial responses
directed against lumenal bacteria is important for controlling
the translocation of gut microbiota.
Collateral Damage and the Exploitation of Host
Responses by Pathogens
One of the characteristics of exudative inflammation is the
formation of exudates that can accumulate in intestinal tissue,
resulting in edema, or when accompanied by significant injury
to the intestinal epithelium, can transfer into the lumen, where
they contribute to diarrhea (Figure 1). Severe acute exudative
inflammation caused by invasive enteric pathogens, such as
Shigella spp. or S. Typhimurium, is associated with extensive
epithelial injury and necrosis of the uppermucosa, affecting large
areas of the colon (in case of Shigella spp.) and/or the terminal
ileum (in case of the bacterium S. Typhimurium) (Santos et al.,
2002; Takeuchi et al., 1968; Tsolis et al., 1999). S. Typhimurium
infection of CD18-deficient calves, whose neutrophils are unable
to extravasate, does not result in this severe epithelial damage
(Nunes et al., 2010). This finding suggests that neutrophils are
largely responsible for the collateral tissue damage accompa-
nying exudative inflammation, thereby contributing to intestinal
fluid accumulation and diarrhea. Diarrhea and the resulting dehy-
dration can become life threatening, which illustrates that the
protection against bacterial translocation and dissemination
conferred by exudative inflammation can come at a high cost
and needs to be tightly controlled to limit the damage inflicted
on the host.
A second potential drawback of exudative inflammation is less
obvious and has been revealed only recently. The lumenal path-
ogen Citrobacter rodentium triggers intestinal inflammation in
mice by deploying a T3SS for intimate attachment to epithelial
cells, resulting in a disruption of tight junctions (Guttman et al.,
2006). This inflammatory response is associated with changes
in the gut microbiota, including an increased abundance of
bacteria belonging to the phylum Proteobacteria, specifically
members of the family Enterobacteriaceae (Lupp et al., 2007).
Similarly, exudative inflammation caused by invasive enteric
pathogens, such as Campylobacter jejuni and S. Typhimurium,
is accompanied by an increased abundance of Enterobacteria-
ceae (Lupp et al., 2007; Stecher et al., 2007). Changes in the
gut microbiota have also been observed in IBD patients, in
whomchronic intestinal inflammation is accompanied bya signif-
icant increase in Enterobacteriaceae and a reduced biodiversity40 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.of bacteria belonging to the phylum Firmicutes (reviewed in
Marteau [2009]). Importantly, intestinal inflammation induced
by pathogens belonging to the Proteobacteria, including
C. rodentium,Campylobacter jejuni, and S. Typhimurium, results
in their overgrowth in the intestinal lumen of mice (Lupp et al.,
2007; Stecher et al., 2007). In the case of S. Typhimurium, the
resulting increase in its lumenal abundance enhances transmis-
sion of the pathogen to a susceptible host, thereby placing
virulence factors important for triggering inflammation under
a positive selection (Lawley et al., 2008; Wickham et al., 2007).
The ability of S. Typhimurium to trigger exudative inflammation
depends on two T3SSs, which mediate invasion of the intestinal
epithelium and subsequent survival within macrophages,
respectively (Tsolis et al., 1999). Mutational inactivation of these
two virulence factors renders S. Typhimurium unable to benefit
from exudative inflammation by outgrowing the gut microbiota
and increasing its transmission success (Lawley et al., 2008;
Stecher et al., 2007).
Pathogens triggering intestinal inflammation take advantage
of at least two environmental changes that accompany this
host response (Figure 3). The first notable alteration of the intes-
tinal environment occurring during inflammation is the removal of
lumenal contents by the flushing action of diarrhea. The remain-
ing microbes in this niche rely predominantly on nutrients found
in themucus layer for supporting their growth (Krivan et al., 1992;
McCormick et al., 1988). The mechanisms by which pathogens
can take advantage of this situation are still poorly understood,
but initial studies suggest that the ability to colonize the mucus
layer plays an important role in their ability to outgrow the
microbiota. For example, S. Typhimurium uses motility and
chemotaxis toward mucus carbohydrates to colonize this niche,
and both properties are essential for benefiting from inflamma-
tion by outgrowing the intestinal microbiota in mice. Importantly,
growth in mucus only provides an advantage during inflamma-
tion, because S. Typhimurium mutants unable to elicit this host
response (due to an inactivation of both T3SSs) can no longer
use motility and chemotaxis to outcompete other gut microbes
(Stecher et al., 2008).
A second important change in the gut environment encoun-
tered during acute exudative inflammation is the epithelial
release of antimicrobials into the lumen. Antimicrobials can influ-
ence the microbiota composition, as segmented filamentous
bacteria (SFB), which are members of the phylum Firmicutes,
are lost from the gut microbial community in mice expressing
a human a-defensin gene (DEFA5) in Paneth cells of the small
intestine (Salzman et al., 2010). Recent evidence suggests that
pathogens triggering inflammation possess virulence mecha-
nisms that render them resistant against antimicrobials, and
this property enhances their competitiveness in the lumen of
the inflamed gut. For instance, one of the antimicrobials released
into the intestinal lumen of Rhesus macaques during inflamma-
tion is lipocalin-2 (Raffatellu et al., 2009), which prevents bacte-
rial iron uptake by binding and inactivating enterobactin, a
low-molecular-weight compound (siderophore) released by
many enteric bacteria to chelate iron and internalize the resulting
complex through specialized outer membrane receptors (Fig-
ure 3). S. Typhimurium synthesizes and releases a glycosylated
derivative of enterobactin, termed salmochelin (Hantke et al.,
2003), which is no longer bound by lipocalin-2, thereby rendering
Figure 3. Differences in the Lumenal Environment of the Normal and the Inflamed Gut
Pathogens triggering intestinal inflammation do not inhabit the same niche as the intestinal microbiota. The microbiota inhabits the normal intestine, an environ-
ment rich in nutrients derived from ingesta. Pathogens use their virulence factors to induce drastic changes in the intestinal environment, including removal of
intestinal contents and the epithelial release of antimicrobials such as lipocalin-2. Lipocalin-2 prevents microbial iron acquisition by sequestering the siderophore
enterobactin. By specializing on growth in the mucus layer and producing siderophores that confer lipocalin-2 resistance (e.g., salmochelin), pathogens can
exploit inflammation during their competition with the microbiota. As a result, the environmental changes encountered in the inflamed gut favor the overgrowth
of pathogens, thereby enhancing their transmission by the fecal/oral route.
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bach et al., 2006). Utilization of salmochelin enhances the ability
of S. Typhimurium to grow in the lumen of the inflamed intestine,
while no benefit is apparent in the absence of intestinal inflam-
mation or in lipocalin-2-deficient mice (Raffatellu et al., 2009).
Thus, resistance against antimicrobials released into the intes-
tinal lumen can enable pathogens to exploit inflammatory
responses during their competition with the gut microbiota.
Concluding Remarks
Recent years have seen a rapid advance in our understanding of
how inflammatory responses help to restrict the translocation
of gut microbiota and prevent the dissemination of bacterial
pathogens. Some of the barrier functions induced during inflam-
mation, such as the responses against lumenal bacteria orches-
trated by the IL-23/IL-22 axis, are just beginning to be explored,
and a more detailed knowledge of these pathways promises to
provide new insights into mechanisms contributing to increased
microbial translocation in HIV-infected individuals and IBD
patients. It has long been appreciated that intestinal inflamma-
tion also comes at a price, since it is associated with collateral
tissue damage and diarrhea. However, the fact that pathogens
have learned to exploit this host response during their competi-
tion with the intestinal microbiota is an important emerging
concept, which remains incompletely understood. Further anal-ysis of themechanisms bywhich pathogens trigger inflammation
to take advantage of the resulting changes in the intestinal envi-
ronment is expected to provide important insights into why some
bacteria evolved to cause gastrointestinal disease.
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